(CUK) Carnival ADS - Overview
Exchange: NYSE •
Country: United States •
Currency: USD •
Type: Common Stock •
ISIN: US14365C1036
Stock: Cruises, Travel, Destinations, Hotels, Transport
Total Rating 41
Risk 51
Buy Signal -1.21
| Risk 5d forecast | |
|---|---|
| Volatility | 56.5% |
| Relative Tail Risk | -12.2% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.85 |
| Alpha | 5.39 |
| Character TTM | |
|---|---|
| Beta | 1.633 |
| Beta Downside | 2.035 |
| Drawdowns 3y | |
|---|---|
| Max DD | 43.10% |
| CAGR/Max DD | 1.01 |
EPS (Earnings per Share)
Revenue
Description: CUK Carnival ADS March 05, 2026
Carnival Plc (CUK) is a cruise company offering leisure travel globally. The company operates under various brands, targeting different market segments within the cruise industry.
Its business model includes direct sales channels and partnerships with travel agencies. The cruise sector is capital-intensive, requiring significant investment in ships and infrastructure.
Carnivals operations are divided into North America, Europe, Cruise Support, and Tour segments. Cruise companies often own and operate ancillary services like hotels and transportation to enhance the traveler experience.
Further research on ValueRay can provide more in-depth analysis of CUKs financial performance and market position.
Piotroski VR‑10 (Strict, 0-10) 5.5
| Net Income: 2.76b TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.05 > 0.02 and ΔFCF/TA 2.40 > 1.0 |
| NWC/Revenue: -33.33% < 20% (prev -32.93%; Δ -0.40% < -1%) |
| CFO/TA 0.12 > 3% & CFO 6.22b > Net Income 2.76b |
| Net Debt (26.07b) to EBITDA (6.89b): 3.78 < 3 |
| Current Ratio: 0.32 > 1.5 & < 3 |
| Outstanding Shares: last quarter (1.40b) vs 12m ago 0.29% < -2% |
| Gross Margin: 37.37% > 18% (prev 0.37%; Δ 3699 % > 0.5%) |
| Asset Turnover: 52.85% > 50% (prev 51.01%; Δ 1.84% > 0%) |
| Interest Coverage Ratio: 3.08 > 6 (EBITDA TTM 6.89b / Interest Expense TTM 1.33b) |
Altman Z'' -0.19
| A: -0.17 (Total Current Assets 4.22b - Total Current Liabilities 13.09b) / Total Assets 51.69b |
| B: 0.09 (Retained Earnings 4.82b / Total Assets 51.69b) |
| C: 0.08 (EBIT TTM 4.10b / Avg Total Assets 50.37b) |
| D: 0.09 (Book Value of Equity 3.38b / Total Liabilities 39.40b) |
| Altman-Z'' Score: -0.19 = B |
Beneish M -2.98
| DSRI: 1.08 (Receivables 678.0m/590.0m, Revenue 26.62b/25.02b) |
| GMI: 1.00 (GM 37.37% / 37.50%) |
| AQI: 1.00 (AQ_t 0.05 / AQ_t-1 0.05) |
| SGI: 1.06 (Revenue 26.62b / 25.02b) |
| TATA: -0.07 (NI 2.76b - CFO 6.22b) / TA 51.69b) |
| Beneish M-Score: -2.98 (Cap -4..+1) = A |
What is the price of CUK shares?
As of March 05, 2026, the stock is trading at USD 27.95 with a total of 2,986,896 shares traded.
Over the past week, the price has changed by -11.41%, over one month by -11.86%, over three months by +18.28% and over the past year by +41.53%.
Over the past week, the price has changed by -11.41%, over one month by -11.86%, over three months by +18.28% and over the past year by +41.53%.
Is CUK a buy, sell or hold?
Carnival ADS has no consensus analysts rating.
What are the forecasts/targets for the CUK price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 35.5 | 27% |
| Analysts Target Price | 35.5 | 27% |
CUK Fundamental Data Overview March 02, 2026
P/E Trailing = 15.5792
P/E Forward = 12.6904
P/S = 1.5516
P/B = 3.3627
P/EG = 1.0911
Revenue TTM = 26.62b USD
EBIT TTM = 4.10b USD
EBITDA TTM = 6.89b USD
Long Term Debt = 24.04b USD (from longTermDebt, last quarter)
Short Term Debt = 2.78b USD (from shortTermDebt, last quarter)
Debt = 27.99b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 26.07b USD (from netDebt column, last quarter)
Enterprise Value = 67.37b USD (41.31b + Debt 27.99b - CCE 1.93b)
Interest Coverage Ratio = 3.08 (Ebit TTM 4.10b / Interest Expense TTM 1.33b)
EV/FCF = 25.84x (Enterprise Value 67.37b / FCF TTM 2.61b)
FCF Yield = 3.87% (FCF TTM 2.61b / Enterprise Value 67.37b)
FCF Margin = 9.79% (FCF TTM 2.61b / Revenue TTM 26.62b)
Net Margin = 10.37% (Net Income TTM 2.76b / Revenue TTM 26.62b)
Gross Margin = 37.37% ((Revenue TTM 26.62b - Cost of Revenue TTM 16.67b) / Revenue TTM)
Gross Margin QoQ = 26.75% (prev 46.22%)
Tobins Q-Ratio = 1.30 (Enterprise Value 67.37b / Total Assets 51.69b)
Interest Expense / Debt = 1.13% (Interest Expense 315.0m / Debt 27.99b)
Taxrate = 0.43% (12.0m / 2.77b)
NOPAT = 4.08b (EBIT 4.10b * (1 - 0.43%))
Current Ratio = 0.32 (Total Current Assets 4.22b / Total Current Liabilities 13.09b)
Debt / Equity = 2.28 (Debt 27.99b / totalStockholderEquity, last quarter 12.28b)
Debt / EBITDA = 3.78 (Net Debt 26.07b / EBITDA 6.89b)
Debt / FCF = 10.00 (Net Debt 26.07b / FCF TTM 2.61b)
Total Stockholder Equity = 10.85b (last 4 quarters mean from totalStockholderEquity)
RoA = 5.48% (Net Income 2.76b / Total Assets 51.69b)
RoE = 25.45% (Net Income TTM 2.76b / Total Stockholder Equity 10.85b)
RoCE = 11.74% (EBIT 4.10b / Capital Employed (Equity 10.85b + L.T.Debt 24.04b))
RoIC = 10.82% (NOPAT 4.08b / Invested Capital 37.70b)
WACC = 7.56% (E(41.31b)/V(69.30b) * Re(11.93%) + D(27.99b)/V(69.30b) * Rd(1.13%) * (1-Tc(0.00)))
Discount Rate = 11.93% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 100.0 | Cagr: 5.40%
[DCF] Terminal Value 72.27% ; FCFF base≈2.08b ; Y1≈1.37b ; Y5≈624.0m
[DCF] Fair Price = N/A (negative equity: EV 13.23b - Net Debt 26.07b = -12.83b; debt exceeds intrinsic value)
EPS Correlation: 66.12 | EPS CAGR: 184.5% | SUE: -2.47 | # QB: 0
Revenue Correlation: 79.44 | Revenue CAGR: 43.75% | SUE: -0.01 | # QB: 0
EPS current Year (2026-11-30): EPS=2.48 | Chg7d=+0.000 | Chg30d=+0.340 | Revisions Net=+1 | Growth EPS=+10.2% | Growth Revenue=+4.7%
EPS next Year (2027-11-30): EPS=2.70 | Chg7d=+0.000 | Chg30d=+0.240 | Revisions Net=+1 | Growth EPS=+8.9% | Growth Revenue=+3.8%
P/E Forward = 12.6904
P/S = 1.5516
P/B = 3.3627
P/EG = 1.0911
Revenue TTM = 26.62b USD
EBIT TTM = 4.10b USD
EBITDA TTM = 6.89b USD
Long Term Debt = 24.04b USD (from longTermDebt, last quarter)
Short Term Debt = 2.78b USD (from shortTermDebt, last quarter)
Debt = 27.99b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 26.07b USD (from netDebt column, last quarter)
Enterprise Value = 67.37b USD (41.31b + Debt 27.99b - CCE 1.93b)
Interest Coverage Ratio = 3.08 (Ebit TTM 4.10b / Interest Expense TTM 1.33b)
EV/FCF = 25.84x (Enterprise Value 67.37b / FCF TTM 2.61b)
FCF Yield = 3.87% (FCF TTM 2.61b / Enterprise Value 67.37b)
FCF Margin = 9.79% (FCF TTM 2.61b / Revenue TTM 26.62b)
Net Margin = 10.37% (Net Income TTM 2.76b / Revenue TTM 26.62b)
Gross Margin = 37.37% ((Revenue TTM 26.62b - Cost of Revenue TTM 16.67b) / Revenue TTM)
Gross Margin QoQ = 26.75% (prev 46.22%)
Tobins Q-Ratio = 1.30 (Enterprise Value 67.37b / Total Assets 51.69b)
Interest Expense / Debt = 1.13% (Interest Expense 315.0m / Debt 27.99b)
Taxrate = 0.43% (12.0m / 2.77b)
NOPAT = 4.08b (EBIT 4.10b * (1 - 0.43%))
Current Ratio = 0.32 (Total Current Assets 4.22b / Total Current Liabilities 13.09b)
Debt / Equity = 2.28 (Debt 27.99b / totalStockholderEquity, last quarter 12.28b)
Debt / EBITDA = 3.78 (Net Debt 26.07b / EBITDA 6.89b)
Debt / FCF = 10.00 (Net Debt 26.07b / FCF TTM 2.61b)
Total Stockholder Equity = 10.85b (last 4 quarters mean from totalStockholderEquity)
RoA = 5.48% (Net Income 2.76b / Total Assets 51.69b)
RoE = 25.45% (Net Income TTM 2.76b / Total Stockholder Equity 10.85b)
RoCE = 11.74% (EBIT 4.10b / Capital Employed (Equity 10.85b + L.T.Debt 24.04b))
RoIC = 10.82% (NOPAT 4.08b / Invested Capital 37.70b)
WACC = 7.56% (E(41.31b)/V(69.30b) * Re(11.93%) + D(27.99b)/V(69.30b) * Rd(1.13%) * (1-Tc(0.00)))
Discount Rate = 11.93% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 100.0 | Cagr: 5.40%
[DCF] Terminal Value 72.27% ; FCFF base≈2.08b ; Y1≈1.37b ; Y5≈624.0m
[DCF] Fair Price = N/A (negative equity: EV 13.23b - Net Debt 26.07b = -12.83b; debt exceeds intrinsic value)
EPS Correlation: 66.12 | EPS CAGR: 184.5% | SUE: -2.47 | # QB: 0
Revenue Correlation: 79.44 | Revenue CAGR: 43.75% | SUE: -0.01 | # QB: 0
EPS current Year (2026-11-30): EPS=2.48 | Chg7d=+0.000 | Chg30d=+0.340 | Revisions Net=+1 | Growth EPS=+10.2% | Growth Revenue=+4.7%
EPS next Year (2027-11-30): EPS=2.70 | Chg7d=+0.000 | Chg30d=+0.240 | Revisions Net=+1 | Growth EPS=+8.9% | Growth Revenue=+3.8%